Tocilizumab for the treatment of severe coronavirus disease 2019-Reference-Cited by-同舟云学术

Tocilizumab for the treatment of severe coronavirus disease 2019

Published:2020-05-10 Issue:10 Volume:92 Page:2042-2049
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:J Med Virol

Author:

Alattar Rand¹,Ibrahim Tawheeda B. H.¹,Shaar Shahd H.¹^ORCID,Abdalla Shiema¹,Shukri Kinda¹,Daghfal Joanne N.¹,Khatib Mohamed Y.²,Aboukamar Mohamed¹,Abukhattab Mohamed¹³^ORCID,Alsoub Hussam A.¹³,Almaslamani Muna A.¹³,Omrani Ali S.¹³^ORCID

Affiliation:

1. Communicable Diseases Center Hamad Medical Corporation Doha Qatar

2. Division of Critical Care and Pulmonary Medicine, Department of Medicine Hamad Medical Corporation Doha Qatar

3. Division of Infectious Diseases, Department of Medicine Hamad Medical Corporation Doha Qatar

Publisher

Wiley

Subject

Infectious Diseases,Virology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmv.25964

Reference30 articles.

1. A Novel Coronavirus from Patients with Pneumonia in China, 2019

2. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2

Cited by 216 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effect of tocilizumab administration on inflammatory markers in COVID-19 patients;The Egyptian Journal of Bronchology;2024-08-17

2. Assessment of adverse events related to anti-interleukin-6 receptor monoclonal antibodies using the FDA adverse event reporting system: a real-world pharmacovigilance study;Expert Opinion on Drug Safety;2024-07-25

3. Differences and similarities between innate immune evasion strategies of human coronaviruses;Current Opinion in Microbiology;2024-06

4. COVID-19 therapy directed against pathogenic mechanisms of severe acute respiratory syndrome coronavirus 2;Molecular Medical Microbiology;2024

5. QTc Prolongation to Predict Mortality in Patients Admitted with COVID- 19 Infection: An Observational Study;Current Vascular Pharmacology;2023-12-08